ARL-15896

Catalog No. A13858

ARL-15896是新型的N-甲基-D-天冬氨酸受体离子通道拮抗剂。
  • Robert A. Volkmann, .et al. MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit, PLoS One, 2016, 11(2): e0148129 PMID: 26829109
Catalog Num A13858
M. Wt 271.19187
Formula C13H16Cl2N2
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 153322-06-6
Synonyms ARL15896, ARL 15896, Lanicemine hydrochloride, AR-R15896AR
SMILES C1=CC=C(C=C1)[C@H](CC2=CC=CC=N2)N
ARL-15896是新型的N-甲基-D-天冬氨酸受体离子通道拮抗剂。
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 36.87 mL 184.37 mL 368.74 mL
0.5 mM 7.37 mL 36.87 mL 73.75 mL
1 mM 3.69 mL 18.44 mL 36.87 mL
5 mM 0.74 mL 3.69 mL 7.37 mL

*The above data is based on the productmolecular weight 271.19187. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.